301 related articles for article (PubMed ID: 20682201)
1. Ocular MECP2 protein expression in patients with and without Rett syndrome.
Jain D; Singh K; Chirumamilla S; Bibat GM; Blue ME; Naidu SR; Eberhart CG
Pediatr Neurol; 2010 Jul; 43(1):35-40. PubMed ID: 20682201
[TBL] [Abstract][Full Text] [Related]
2. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
3. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N
Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
5. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
[TBL] [Abstract][Full Text] [Related]
6. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
[TBL] [Abstract][Full Text] [Related]
8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
9. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
11. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
12. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
14. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
15. The role of MeCP2 in CNS development and function.
Na ES; Monteggia LM
Horm Behav; 2011 Mar; 59(3):364-8. PubMed ID: 20515694
[TBL] [Abstract][Full Text] [Related]
16. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
Bissonnette JM; Knopp SJ
Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
[TBL] [Abstract][Full Text] [Related]
17. Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain.
Armstrong DD; Deguchi K; Antallfy B
J Child Neurol; 2003 Oct; 18(10):683-7. PubMed ID: 14649549
[TBL] [Abstract][Full Text] [Related]
18. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
Pohodich AE; Zoghbi HY
Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in the gene body influences MeCP2-mediated gene repression.
Kinde B; Wu DY; Greenberg ME; Gabel HW
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
